bpc 157 human clinical trial evidence safety fda warning bpc-157 Thinking about trying BPC-157? Read this first. While often marketed as a “healing peptide” BPC-157 is not FDA approved and not pharmacy grade FDA's Overreach on Compounded Peptides

chest pain

It is interesting that the endocrine and paracrine/autocrine changes in the insulin-GH-IGF-axis observed in children with type 1 diabetes closely resembles those observed in liver IGF-I KO mice which eventually leads to diabetes in the KO mice

One of the RCTs found significant mean improvements in Clinical Global Impressions-Improvement (CGI-I) score and cellular methylation capacity, but not in the Aberrant Behaviour Checklist (ABC), Social Responsiveness Scale (SRS) or GSH metabolism, with those who had the lowest methionine status at baseline (suggesting impaired methylation capacity) significantly more likely to respond to supplementation

Unlike full HGH, it does not raise IGF-1, does not affect blood sugar, does not stimulate growth in non-fat tissue, and does not interfere with the pituitary's own growth hormone signalling